ID   CRFR1_RAT               Reviewed;         415 AA.
AC   P35353;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   02-OCT-2024, entry version 178.
DE   RecName: Full=Corticotropin-releasing factor receptor 1;
DE            Short=CRF-R-1;
DE            Short=CRF-R1;
DE            Short=CRFR-1;
DE   AltName: Full=Corticotropin-releasing hormone receptor 1;
DE            Short=CRH-R-1;
DE            Short=CRH-R1;
DE   Flags: Precursor;
GN   Name=Crhr1; Synonyms=Crhr;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=8243338; DOI=10.1210/endo.133.6.8243338;
RA   Perrin M.H., Donaldson C.J., Chen R., Lewis K.A., Vale W.W.;
RT   "Cloning and functional expression of a rat brain corticotropin releasing
RT   factor (CRF) receptor.";
RL   Endocrinology 133:3058-3061(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Cerebellum;
RX   PubMed=8274282; DOI=10.1016/0896-6273(93)90230-o;
RA   Chang C.P., Pearse R.V. II, O'Connell S., Rosenfeld M.G.;
RT   "Identification of a seven transmembrane helix receptor for corticotropin-
RT   releasing factor and sauvagine in mammalian brain.";
RL   Neuron 11:1187-1195(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Testis;
RX   PubMed=8662941; DOI=10.1074/jbc.271.24.14519;
RA   Tsai-Morris C.-H., Buczko E., Geng Y., Gamboa-Pinto A., Dufau M.L.;
RT   "The genomic structure of the rat corticotropin releasing factor receptor.
RT   A member of the class II G protein-coupled receptors.";
RL   J. Biol. Chem. 271:14519-14525(1996).
RN   [4]
RP   FUNCTION, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-38; ASN-45; ASN-78;
RP   ASN-90 AND ASN-98.
RX   PubMed=11567096; DOI=10.1110/ps.12101;
RA   Hofmann B.A., Sydow S., Jahn O., van Werven L., Liepold T., Eckart K.,
RA   Spiess J.;
RT   "Functional and protein chemical characterization of the N-terminal domain
RT   of the rat corticotropin-releasing factor receptor 1.";
RL   Protein Sci. 10:2050-2062(2001).
RN   [5]
RP   SUBUNIT.
RX   PubMed=23300088; DOI=10.1074/jbc.m112.412478;
RA   Akama K.T., Thompson L.I., Milner T.A., McEwen B.S.;
RT   "Post-synaptic density-95 (PSD-95) binding capacity of G-protein-coupled
RT   receptor 30 (GPR30), an estrogen receptor that can be identified in
RT   hippocampal dendritic spines.";
RL   J. Biol. Chem. 288:6438-6450(2013).
CC   -!- FUNCTION: G-protein coupled receptor for CRH (corticotropin-releasing
CC       factor) and UCN (urocortin). Has high affinity for CRH and UCN. Ligand
CC       binding causes a conformation change that triggers signaling via
CC       guanine nucleotide-binding proteins (G proteins) and down-stream
CC       effectors, such as adenylate cyclase. Promotes the activation of
CC       adenylate cyclase, leading to increased intracellular cAMP levels.
CC       Inhibits the activity of the calcium channel CACNA1H. Required for
CC       normal embryonic development of the adrenal gland and for normal
CC       hormonal responses to stress. Plays a role in the response to
CC       anxiogenic stimuli. {ECO:0000269|PubMed:11567096,
CC       ECO:0000269|PubMed:8243338, ECO:0000269|PubMed:8274282}.
CC   -!- SUBUNIT: Interacts (via N-terminal extracellular domain) with CRH and
CC       UCN. Interacts with DLG1; this inhibits endocytosis of CRHR1 after
CC       agonist binding (By similarity). Heterodimer; heterodimerizes with
CC       GPER1. {ECO:0000250, ECO:0000269|PubMed:23300088}.
CC   -!- INTERACTION:
CC       P35353; P55090: Ucn; NbExp=3; IntAct=EBI-9030306, EBI-9030248;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Endosome {ECO:0000250}. Note=Agonist-binding promotes endocytosis.
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Detected in brain, especially in cerebellum.
CC       Detected in pituitary gland, and at lower levels in the olfactory bulb.
CC       {ECO:0000269|PubMed:8274282}.
CC   -!- DOMAIN: The transmembrane domain is composed of seven transmembrane
CC       helices that are arranged in V-shape. Transmembrane helix 7 assumes a
CC       sharply kinked structure (By similarity). {ECO:0000250}.
CC   -!- PTM: C-terminal Ser or Thr residues may be phosphorylated.
CC   -!- PTM: Phosphorylation at Ser-301 by PKA prevents maximal coupling to Gq-
CC       protein, and thereby negatively regulates downstream signaling.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 2 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L24096; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; L25438; AAA16441.1; -; mRNA.
DR   EMBL; U53498; AAC53519.1; -; Genomic_DNA.
DR   EMBL; U53486; AAC53519.1; JOINED; Genomic_DNA.
DR   EMBL; U53487; AAC53519.1; JOINED; Genomic_DNA.
DR   EMBL; U53488; AAC53519.1; JOINED; Genomic_DNA.
DR   EMBL; U53489; AAC53519.1; JOINED; Genomic_DNA.
DR   EMBL; U53490; AAC53519.1; JOINED; Genomic_DNA.
DR   EMBL; U53491; AAC53519.1; JOINED; Genomic_DNA.
DR   EMBL; U53492; AAC53519.1; JOINED; Genomic_DNA.
DR   EMBL; U53493; AAC53519.1; JOINED; Genomic_DNA.
DR   EMBL; U53494; AAC53519.1; JOINED; Genomic_DNA.
DR   EMBL; U53495; AAC53519.1; JOINED; Genomic_DNA.
DR   EMBL; U53496; AAC53519.1; JOINED; Genomic_DNA.
DR   EMBL; U53497; AAC53519.1; JOINED; Genomic_DNA.
DR   PIR; I58144; I58144.
DR   RefSeq; NP_112261.1; NM_030999.4.
DR   AlphaFoldDB; P35353; -.
DR   SMR; P35353; -.
DR   BioGRID; 248692; 4.
DR   IntAct; P35353; 1.
DR   STRING; 10116.ENSRNOP00000006764; -.
DR   BindingDB; P35353; -.
DR   ChEMBL; CHEMBL4649; -.
DR   GuidetoPHARMACOLOGY; 212; -.
DR   GlyCosmos; P35353; 5 sites, No reported glycans.
DR   GlyGen; P35353; 5 sites.
DR   iPTMnet; P35353; -.
DR   PhosphoSitePlus; P35353; -.
DR   PaxDb; 10116-ENSRNOP00000006764; -.
DR   Ensembl; ENSRNOT00055049662; ENSRNOP00055040862; ENSRNOG00055028694.
DR   Ensembl; ENSRNOT00060025266; ENSRNOP00060020129; ENSRNOG00060014769.
DR   Ensembl; ENSRNOT00065054188; ENSRNOP00065044592; ENSRNOG00065031411.
DR   GeneID; 58959; -.
DR   KEGG; rno:58959; -.
DR   AGR; RGD:61276; -.
DR   CTD; 1394; -.
DR   RGD; 61276; Crhr1.
DR   VEuPathDB; HostDB:ENSRNOG00000004900; -.
DR   eggNOG; KOG4564; Eukaryota.
DR   HOGENOM; CLU_002753_4_1_1; -.
DR   InParanoid; P35353; -.
DR   OrthoDB; 5345963at2759; -.
DR   PhylomeDB; P35353; -.
DR   TreeFam; TF315710; -.
DR   Reactome; R-RNO-373080; Class B/2 (Secretin family receptors).
DR   PRO; PR:P35353; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000004900; Expressed in cerebellum and 3 other cell types or tissues.
DR   ExpressionAtlas; P35353; baseline and differential.
DR   GO; GO:0045177; C:apical part of cell; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005771; C:multivesicular body; IDA:RGD.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0098839; C:postsynaptic density membrane; ISO:RGD.
DR   GO; GO:0005802; C:trans-Golgi network; IDA:RGD.
DR   GO; GO:0031982; C:vesicle; IDA:RGD.
DR   GO; GO:0015056; F:corticotrophin-releasing factor receptor activity; ISS:UniProtKB.
DR   GO; GO:0051424; F:corticotropin-releasing hormone binding; IDA:RGD.
DR   GO; GO:0043404; F:corticotropin-releasing hormone receptor activity; IDA:RGD.
DR   GO; GO:0008528; F:G protein-coupled peptide receptor activity; IBA:GO_Central.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IDA:RGD.
DR   GO; GO:0001965; F:G-protein alpha-subunit binding; IPI:RGD.
DR   GO; GO:0042277; F:peptide binding; IDA:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IDA:RGD.
DR   GO; GO:0007188; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; IDA:RGD.
DR   GO; GO:0030325; P:adrenal gland development; ISO:RGD.
DR   GO; GO:0048148; P:behavioral response to cocaine; IMP:RGD.
DR   GO; GO:0048149; P:behavioral response to ethanol; ISO:RGD.
DR   GO; GO:0048266; P:behavioral response to pain; IMP:RGD.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0071376; P:cellular response to corticotropin-releasing hormone stimulus; ISS:UniProtKB.
DR   GO; GO:0051458; P:corticotropin secretion; ISS:UniProtKB.
DR   GO; GO:0030855; P:epithelial cell differentiation; IMP:RGD.
DR   GO; GO:0035640; P:exploration behavior; ISO:RGD.
DR   GO; GO:0042596; P:fear response; ISO:RGD.
DR   GO; GO:0007631; P:feeding behavior; IMP:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0051867; P:general adaptation syndrome, behavioral process; ISO:RGD.
DR   GO; GO:0021854; P:hypothalamus development; IEP:RGD.
DR   GO; GO:0035641; P:locomotory exploration behavior; IMP:RGD.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IMP:RGD.
DR   GO; GO:0007613; P:memory; IMP:RGD.
DR   GO; GO:0032811; P:negative regulation of epinephrine secretion; IMP:RGD.
DR   GO; GO:2000252; P:negative regulation of feeding behavior; IMP:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; IDA:RGD.
DR   GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; IDA:RGD.
DR   GO; GO:0043950; P:positive regulation of cAMP-mediated signaling; IMP:RGD.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IMP:RGD.
DR   GO; GO:0043306; P:positive regulation of mast cell degranulation; IMP:RGD.
DR   GO; GO:2000852; P:regulation of corticosterone secretion; ISS:UniProtKB.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; IMP:RGD.
DR   GO; GO:0051602; P:response to electrical stimulus; IMP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IMP:RGD.
DR   GO; GO:0035902; P:response to immobilization stress; IEP:RGD.
DR   GO; GO:0008542; P:visual learning; IMP:RGD.
DR   CDD; cd15445; 7tmB1_CRF-R1; 1.
DR   Gene3D; 4.10.1240.10; GPCR, family 2, extracellular hormone receptor domain; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR050332; GPCR_2.
DR   InterPro; IPR017981; GPCR_2-like_7TM.
DR   InterPro; IPR003052; GPCR_2_CRF1_rcpt.
DR   InterPro; IPR003051; GPCR_2_CRF_rcpt.
DR   InterPro; IPR036445; GPCR_2_extracell_dom_sf.
DR   InterPro; IPR001879; GPCR_2_extracellular_dom.
DR   InterPro; IPR000832; GPCR_2_secretin-like.
DR   InterPro; IPR017983; GPCR_2_secretin-like_CS.
DR   PANTHER; PTHR45620:SF2; CORTICOTROPIN-RELEASING FACTOR RECEPTOR 1; 1.
DR   PANTHER; PTHR45620; PDF RECEPTOR-LIKE PROTEIN-RELATED; 1.
DR   Pfam; PF00002; 7tm_2; 1.
DR   Pfam; PF02793; HRM; 1.
DR   PRINTS; PR01279; CRFRECEPTOR.
DR   PRINTS; PR01280; CRFRECEPTOR1.
DR   PRINTS; PR00249; GPCRSECRETIN.
DR   SMART; SM00008; HormR; 1.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   SUPFAM; SSF111418; Hormone receptor domain; 1.
DR   PROSITE; PS00649; G_PROTEIN_RECEP_F2_1; 1.
DR   PROSITE; PS00650; G_PROTEIN_RECEP_F2_2; 1.
DR   PROSITE; PS50227; G_PROTEIN_RECEP_F2_3; 1.
DR   PROSITE; PS50261; G_PROTEIN_RECEP_F2_4; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Disulfide bond; Endosome; G-protein coupled receptor;
KW   Glycoprotein; Membrane; Phosphoprotein; Receptor; Reference proteome;
KW   Signal; Transducer; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..23
FT   CHAIN           24..415
FT                   /note="Corticotropin-releasing factor receptor 1"
FT                   /id="PRO_0000012816"
FT   TOPO_DOM        24..111
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        112..142
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        143..149
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        150..174
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        175..189
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        190..218
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        219..225
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        226..253
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        254..269
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        270..295
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        296..306
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        307..331
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        332..338
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        339..368
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        369..415
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   REGION          99..108
FT                   /note="Important for peptide agonist binding"
FT                   /evidence="ECO:0000250"
FT   REGION          280..290
FT                   /note="Important for antagonist binding"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         301
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:P34998"
FT   CARBOHYD        38
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:11567096"
FT   CARBOHYD        45
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:11567096"
FT   CARBOHYD        78
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:11567096"
FT   CARBOHYD        90
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:11567096"
FT   CARBOHYD        98
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:11567096"
FT   DISULFID        30..54
FT                   /evidence="ECO:0000269|PubMed:11567096"
FT   DISULFID        44..87
FT                   /evidence="ECO:0000269|PubMed:11567096"
FT   DISULFID        68..102
FT                   /evidence="ECO:0000269|PubMed:11567096"
FT   DISULFID        188..258
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   415 AA;  47842 MW;  48D6704B31D4C013 CRC64;
     MGRRPQLRLV KALLLLGLNP VSTSLQDQRC ENLSLTSNVS GLQCNASVDL IGTCWPRSPA
     GQLVVRPCPA FFYGVRYNTT NNGYRECLAN GSWAARVNYS ECQEILNEEK KSKVHYHVAV
     IINYLGHCIS LVALLVAFVL FLRLRSIRCL RNIIHWNLIS AFILRNATWF VVQLTVSPEV
     HQSNVAWCRL VTAAYNYFHV TNFFWMFGEG CYLHTAIVLT YSTDRLRKWM FVCIGWGVPF
     PIIVAWAIGK LHYDNEKCWF GKRPGVYTDY IYQGPMILVL LINFIFLFNI VRILMTKLRA
     STTSETIQYR KAVKATLVLL PLLGITYMLF FVNPGEDEVS RVVFIYFNSF LESFQGFFVS
     VFYCFLNSEV RSAIRKRWRR WQDKHSIRAR VARAMSIPTS PTRVSFHSIK QSTAV
//
